Exane BNP Paribas
(2.85)
Rank
#83 (of 499)
Total Ratings
552
Success Rate
Average Return
10 Covered Stocks (rated in the last 12 months)
| Company | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
SNY Sanofi | Downgrade: Hold | n/a | 48.39 | n/a | 2 | Apr 20, 2026 | |
BCS Barclays PLC | Downgrade: Hold | n/a | 22.4 | n/a | 8 | Apr 14, 2026 | |
HSBC HSBC Holdings plc | Downgrade: Hold | n/a | 88.15 | n/a | 5 | Apr 14, 2026 |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.